Literature DB >> 2386201

AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product.

G T Westermark1, K Sletten, A Grubb, P Westermark.   

Abstract

Protein AA, the major repetitive protein subunit present in fibrils deposited in AA-amyloidosis, is an N-terminal cleavage product of a 104-amino acid precursor, serum amyloid A (SAA). Protein AA subspecies varying between 45 and 94 amino acids in length have been described. In this study it is shown that the different protein AA subspecies are not evenly distributed in amyloid deposits and that in single patients, certain subspecies of protein AA are deposited in specific tissue component sites. Thus larger protein AA subspecies occur in lower concentration in amyloid in the glomeruli compared to other sites and are especially found in amyloid in vessel walls. Three different SAA forms have been predicted from genomic and complementary DNA studies. The existence of a fourth type has been suspected from amino acid sequence studies of purified SAA. Protein AA derived from this fourth type of SAA is now shown to be present in amyloid fibrils in one of the patients studied in this paper.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386201      PMCID: PMC1877615     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Amino acid sequence of amyloid-related apoprotein (apoSAA1) from human high-density lipoprotein.

Authors:  D C Parmelee; K Titani; L H Ericsson; N Eriksen; E P Benditt; K A Walsh
Journal:  Biochemistry       Date:  1982-07-06       Impact factor: 3.162

2.  A serum AA-like protein as a common constituent of secondary amyloid fibrils.

Authors:  P Westermark; K Sletten
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

3.  Bovine amyloid protein AA: isolation and amino acid sequence analysis.

Authors:  P Westermark; K H Johnson; G T Westermark; K Sletten; D W Hayden
Journal:  Comp Biochem Physiol B       Date:  1986

4.  Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA.

Authors:  J D Sipe; H R Colten; G Goldberger; M D Edge; B F Tack; A S Cohen; A S Whitehead
Journal:  Biochemistry       Date:  1985-06-04       Impact factor: 3.162

5.  The covalent structure of amyloid-related serum protein SAA from two patients with inflammatory disease.

Authors:  K Sletten; G Marhaug; G Husby
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1983-08

6.  DNA sequence evidence for polymorphic forms of human serum amyloid A (SAA).

Authors:  B Kluve-Beckerman; G L Long; M D Benson
Journal:  Biochem Genet       Date:  1986-12       Impact factor: 1.890

7.  Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo.

Authors:  A Husebekk; B Skogen; G Husby; G Marhaug
Journal:  Scand J Immunol       Date:  1985-03       Impact factor: 3.487

8.  Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation.

Authors:  R L Meek; J S Hoffman; E P Benditt
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

9.  Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products.

Authors:  J S Hoffman; L H Ericsson; N Eriksen; K A Walsh; E P Benditt
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

10.  Amyloid A gene family expression in different mouse tissues.

Authors:  R L Meek; E P Benditt
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  9 in total

1.  Acute-phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis.

Authors:  Roman Thaler; Ines Sturmlechner; Silvia Spitzer; Scott M Riester; Monika Rumpler; Jochen Zwerina; Klaus Klaushofer; Andre J van Wijnen; Franz Varga
Journal:  FASEB J       Date:  2014-12-09       Impact factor: 5.191

2.  Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literature.

Authors:  Adarsh Babu; Helen Lachmann; Tom Pickett; Preetham Boddana; Linmarie Ludeman
Journal:  CEN Case Rep       Date:  2013-08-09

3.  Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Richard J Charnigo; Ailing Ji; Nancy R Webb; Frederick C de Beer; Deneys R van der Westhuyzen
Journal:  J Lipid Res       Date:  2016-03-27       Impact factor: 5.922

4.  Revisiting misfolding propensity of serum amyloid A1: Special focus on the signal peptide region.

Authors:  Morgan S Haines; Eduardo Ramirez; Kendall B E Moore; Jessica S Fortin
Journal:  Biochem Biophys Rep       Date:  2022-05-30

5.  Human serum amyloid A protein. Complete amino acid sequence of a new variant.

Authors:  C M Beach; M C De Beer; J D Sipe; L D Loose; F C De Beer
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

6.  Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis.

Authors:  H Patel; J Bramall; H Waters; M C De Beer; P Woo
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

Review 7.  The cytokine-serum amyloid A-chemokine network.

Authors:  Mieke De Buck; Mieke Gouwy; Ji Ming Wang; Jacques Van Snick; Paul Proost; Sofie Struyf; Jo Van Damme
Journal:  Cytokine Growth Factor Rev       Date:  2015-12-28       Impact factor: 7.638

8.  Germ line origin and somatic mutations determine the target tissues in systemic AL-amyloidosis.

Authors:  Stina Enqvist; Knut Sletten; Fred J Stevens; Ulf Hellman; Per Westermark
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

9.  Proteomic analysis of highly prevalent amyloid A amyloidosis endemic to endangered island foxes.

Authors:  Patricia M Gaffney; Denise M Imai; Deana L Clifford; Majid Ghassemian; Roman Sasik; Aaron N Chang; Timothy D O'Brien; Judith Coppinger; Margarita Trejo; Eliezer Masliah; Linda Munson; Christina Sigurdson
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.